Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Tax Provisions: 2020-2021

Historic Tax Provisions for Insight Molecular Diagnostics (IMDX) over the last 2 years, with Dec 2021 value amounting to -$97,000.

  • Insight Molecular Diagnostics' Tax Provisions fell 161.01% to -$97,000 in Q4 2021 from the same period last year, while for Dec 2021 it was -$5.7 million, marking a year-over-year change of. This contributed to the annual value of -$8.1 million for FY2022, which is 12.90% up from last year.
  • Insight Molecular Diagnostics' Tax Provisions amounted to -$97,000 in Q4 2021, which was down 105.41% from $1.8 million recorded in Q2 2021.
  • In the past 5 years, Insight Molecular Diagnostics' Tax Provisions ranged from a high of $1.8 million in Q2 2021 and a low of -$7.6 million during Q1 2021.
  • For the 2-year period, Insight Molecular Diagnostics' Tax Provisions averaged around -$1.1 million, with its median value being $31,000 (2020).
  • Over the last 5 years, Insight Molecular Diagnostics' Tax Provisions had its largest YoY gain of 181.92% in 2021, and its largest YoY loss of 790.78% in 2021.
  • Over the past 2 years, Insight Molecular Diagnostics' Tax Provisions (Quarterly) stood at $159,000 in 2020, then crashed by 161.01% to -$97,000 in 2021.
  • Its last three reported values are -$97,000 in Q4 2021, $1.8 million for Q2 2021, and -$7.6 million during Q1 2021.